Yujiro Hata - Aug 19, 2021 Form 3 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
Director
Signature
/s/ Nathaniel S. Gardiner as attorney-in-fact
Stock symbol
ENTA
Transactions as of
Aug 19, 2021
Transactions value $
$0
Form type
3
Date filed
8/23/2021, 04:38 PM
Previous filing
Jun 25, 2021
Next filing
Mar 2, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 Power of Attorney filed herewith.